Related Experiment Videos
[Novel mutations identified in exon 7 of phenylalanine hydroxylase gene in Chinese]
Insights
Researchers identified novel mutations in the phenylalanine hydroxylase (PAH) gene in Chinese children with phenylketonuria (PKU). This genetic analysis reveals population-specific PAH mutations, aiding PKU molecular diagnostics.
Area of Science:
- Genetics
- Molecular Biology
- Human Disease Genetics
Context:
- Phenylketonuria (PKU) is a genetic disorder.
- The phenylalanine hydroxylase (PAH) gene is responsible for PKU.
- Understanding PAH gene mutations is crucial for diagnosis and treatment.
Purpose:
- To analyze exon 7 of the PAH gene in Chinese PKU patients.
- To identify novel mutations and understand PAH mutation distribution in northern China.
- To improve molecular diagnostic capabilities for PKU.
Summary:
- PCR-single strand conformation polymorphism (PCR-SSCP) and DNA sequencing were used to analyze 45 children with classic PKU from northern China.
- Six missense mutations (R243Q, R241H, G247V, L249H, P254I, G257V) and one silent mutation (V245V) were identified in exon 7 of the PAH gene.
- Three missense mutations are novel, and one (R241H) is newly documented in the Chinese population, indicating regional PAH mutation diversity.
Impact:
- Identified novel PAH mutations, enhancing PKU molecular diagnostic capabilities.
- Revealed population and regional differences in PAH mutation distribution in China.
- Suggests multiple founding populations for PKU in China, informing genetic studies.
Abstract:
Exon 7 of the phenylalanine hydroxylase (PAH) gene was analyzed in 45 children affected with classic phenylketonuria (PKU) from northern China by using PCR-single strand conformation polymorphism (PCR-SSCP) technique and DNA direct sequencing. Six missense mutations (i.e. R243Q, R241H, G247V, L249H, P254I and G257V) and one silent mutation (V245V) were identified. The latter three missense mutations were demonstrated as novel mutations in comparison with the PAH mutation Database. One missense mutation (R241H) was first documented in Chinese. Our results showed population and regional differences in the PAH mutation distribution and suggest that there is more than one founding population for PKU in China. The finding of novel mutations will enhance our capability in molecular diagnosis of PKU.